DEBORAH HORWITZ: Open Payments
NPI 1518239607 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 51 payments from 13 companies in 2025. Trend: 2023 $181 · 2024 $1,367 · 2025 $2,637
Food & beverage: $1,996Consulting: $638Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 9 | $1,387 |
| ABBVIE INC. | 12 | $271 |
| Galderma Laboratories, L.P. | 2 | $188 |
| Lilly USA, LLC | 4 | $180 |
| PFIZER INC. | 6 | $136 |
| Amgen Inc. | 3 | $97 |
| GENZYME CORPORATION | 3 | $91 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Arcutis Biotherapeutics, Inc. | 2 | $48 |
Products named: ADBRY, SKYRIZI, ANZUPGO, NEMLUVIO, EBGLYSS, CIBINQO, DUPIXENT, OTEZLA.
Industry payments across MD — which companies pay providers there.
